• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonadherence to Referral Colonoscopy After Positive Fecal Immunochemical Test Results Increases the Risk of Distal Colorectal Cancer Mortality.

作者信息

Zhu Yingshuang, Li Xue, Hu Yeting, Chen Kun, Zheng Shu, Ding Kefeng

机构信息

Department of Colorectal Surgery and Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Center for Medical Research and Innovation in Digestive System Tumors, Ministry of Education, Hangzhou, China; Zhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, China; Cancer Center of Zhejiang University, Hangzhou, Zhejiang, China.

Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Gastroenterology. 2023 Dec;165(6):1558-1560.e4. doi: 10.1053/j.gastro.2023.08.013. Epub 2023 Aug 19.

DOI:10.1053/j.gastro.2023.08.013
PMID:37598799
Abstract
摘要

相似文献

1
Nonadherence to Referral Colonoscopy After Positive Fecal Immunochemical Test Results Increases the Risk of Distal Colorectal Cancer Mortality.粪便免疫化学检测结果呈阳性后未坚持接受转诊结肠镜检查会增加远端结直肠癌死亡风险。
Gastroenterology. 2023 Dec;165(6):1558-1560.e4. doi: 10.1053/j.gastro.2023.08.013. Epub 2023 Aug 19.
2
Do socioeconomic factors play a role in nonadherence to follow-up colonoscopy after a positive faecal immunochemical test in the Flemish colorectal cancer screening programme?社会经济因素是否在弗拉芒结直肠癌筛查计划中阳性粪便免疫化学试验后不遵医嘱进行结肠镜随访中起作用？
Eur J Cancer Prev. 2020 Mar;29(2):119-126. doi: 10.1097/CEJ.0000000000000533.
3
Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers.结肠镜检查不依从者的结直肠癌死亡率与粪便血红蛋白浓度梯度之间的关联
J Natl Cancer Inst. 2017 May 1;109(5). doi: 10.1093/jnci/djw269.
4
A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.新一代粪便免疫化学检测（FIT）在结肠镜检查转诊患者中检测结直肠肿瘤方面优于基于愈创木脂的检测。
Anticancer Res. 2015 May;35(5):2873-80.
5
Factors affecting compliance with confirmatory colonoscopy after a positive fecal immunochemical test in a national colorectal screening program.影响全国结直肠筛查计划中粪便免疫化学检测阳性后行确认性结肠镜检查依从性的因素。
Cancer. 2018 Mar 1;124(5):907-915. doi: 10.1002/cncr.31145. Epub 2017 Nov 22.
6
Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).单纯使用年度粪便免疫化学试验筛查与单次结肠镜检查相结合对降低结直肠癌死亡率的效果：日本秋田人群为基础的结肠镜筛查试验（秋田人群结肠镜筛查试验）。
Int J Colorectal Dis. 2020 May;35(5):933-939. doi: 10.1007/s00384-020-03518-w. Epub 2020 Feb 7.
7
Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.基于人群的结直肠癌筛查中结肠镜检查和粪便免疫化学检测的优化使用：一项使用日本数据的成本效益分析
Jpn J Clin Oncol. 2016 Feb;46(2):116-25. doi: 10.1093/jjco/hyv186. Epub 2015 Dec 18.
8
Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.基于粪便的结直肠癌筛查和阳性检测后结肠镜检查中患者依从性对临床结局的影响。
Cancer Prev Res (Phila). 2021 Sep;14(9):845-850. doi: 10.1158/1940-6207.CAPR-21-0075. Epub 2021 May 21.
9
Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.新一代粪便免疫化学检测（FIT）与愈创木脂粪便潜血试验（gFOBT）在结肠镜转诊患者中检测结直肠肿瘤的比较。
Anticancer Res. 2019 Jan;39(1):261-269. doi: 10.21873/anticanres.13106.
10
Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.多靶点粪便DNA检测增加了既往不依从的医疗保险患者的结直肠癌筛查率。
World J Gastroenterol. 2017 Jan 21;23(3):464-471. doi: 10.3748/wjg.v23.i3.464.

引用本文的文献

1
Fecal immunochemical test surveillance in colorectal cancer following adenoma resection: A longitudinal, population-based linked cohort study in China.腺瘤切除术后结直肠癌的粪便免疫化学检测监测：中国一项基于人群的纵向队列关联研究。
PLoS Med. 2025 Sep 2;22(9):e1004687. doi: 10.1371/journal.pmed.1004687. eCollection 2025 Sep.
2
Global burden, trends, and risk factors of early-onset and late-onset colorectal cancer from 1990 to 2021, with projections to 2040: a population-based study.1990年至2021年早发性和晚发性结直肠癌的全球负担、趋势及风险因素，并预测至2040年：一项基于人群的研究
BMC Gastroenterol. 2025 Jul 1;25(1):486. doi: 10.1186/s12876-025-04086-5.
3
Development of Electronic Nose as a Complementary Screening Tool for Breath Testing in Colorectal Cancer.
电子鼻作为结直肠癌呼气检测辅助筛查工具的开发
Biosensors (Basel). 2025 Feb 1;15(2):82. doi: 10.3390/bios15020082.
4
Diagnostic and Prognostic Significance of a Four-miRNA Signature in Colorectal Cancer.四种miRNA特征在结直肠癌中的诊断和预后意义
Int J Mol Sci. 2025 Jan 30;26(3):1219. doi: 10.3390/ijms26031219.
5
Fecal occult blood affects intestinal microbial community structure in colorectal cancer.粪便潜血影响结直肠癌患者的肠道微生物群落结构。
BMC Microbiol. 2025 Jan 20;25(1):34. doi: 10.1186/s12866-024-03721-7.
6
Developing an optimal stratification model for colorectal cancer screening and reducing racial disparities in multi-center population-based studies.在多中心基于人群的研究中开发用于结直肠癌筛查的优化分层模型并减少种族差异。
Genome Med. 2024 Jun 13;16(1):81. doi: 10.1186/s13073-024-01355-y.
7
Colonoscopy Outreach for Rural Communities (CORC): A study protocol of a pragmatic randomized controlled trial of a patient navigation program to improve colonoscopy completion for colorectal cancer screening.结肠镜下乡（CORC）：一项患者导航方案的实用随机对照试验研究方案，旨在提高结直肠癌筛查的结肠镜检查完成率。
Contemp Clin Trials. 2024 Jun;141:107539. doi: 10.1016/j.cct.2024.107539. Epub 2024 Apr 12.